Skip to main content
Premium Trial:

Request an Annual Quote

GigaScience Selects Aspera's Software to Move Research Data

Premium

Aspera said this week that GigaScience — an online open-access, open-data life sciences journal, co-published by BGI and BioMed Central — has licensed its software products to provide authors, reviewers, and other users with tools to upload and download large datasets that accompany submitted manuscripts.

Aspera said that GigaScience selected its Aspera Connect Server and Aspera Console to enable the transfer of the datasets and to manage and monitor the transfer process.

GigaScience publishes articles that span the full spectrum of biological and biomedical sciences and focus on the use, analysis, or tool development for large-scale data sets. It also hosts the complete datasets associated with each published article in a comprehensive public database, GigaDB.

Manuscript authors will now be able to use Aspera's free Connect Web Browser plug-in to submit manuscript-associated datasets to a private data storage site at GigaScience that staff reviewers will be able access and download data from. If a paper is accepted for publishing, the data will then be transferred to GigaDB where it will be readily available for readers to download.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.